<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/cntx" ></link>
<id>urn:uuid:174e8187-b737-4d07-41b8-b89a381adc8b</id>
<updated>2026-05-03T21:23:25-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>CNTX: LEHR MARTIN A (CEO,DIR) Bought (B) 100k Shares of CONTEXT THERAPEUTICS INC for $0.70 on 6/9</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-6213547" ></link>
<id>urn:uuid:fd566539-ef77-7525-00b5-eee8e313fda0</id>
<updated>2025-06-10T17:26:21-04:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>CNTX: MINAI AZARY JENNIFER LYNN (CFO) Bought (B) 40,010 Shares of CONTEXT THERAPEUTICS INC for $0.64 on 6/6</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-6213539" ></link>
<id>urn:uuid:fa55ce61-b20f-291b-fba9-e6bb43c2d17b</id>
<updated>2025-06-10T17:22:20-04:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>CNTX: CHAGIN KAREN DEBORAH (O) Filed a Form 3, Becoming a Registered Insider at CONTEXT THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-6212562" ></link>
<id>urn:uuid:03ce1314-3404-3827-c746-0912c00a5c72</id>
<updated>2025-06-09T17:13:50-04:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>CNTX: PASTERNAK ANDY (DIR) Filed a Form 3, Becoming a Registered Insider at CONTEXT THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-6113153" ></link>
<id>urn:uuid:c6a14281-77e9-a250-c487-9a6c58a9de5b</id>
<updated>2025-01-14T20:36:50-05:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>CNTX: SMITH KAREN L (DIR) Filed a Form 3, Becoming a Registered Insider at CONTEXT THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-6053452" ></link>
<id>urn:uuid:85ceac98-f214-398d-d473-b713de960a4a</id>
<updated>2024-09-05T08:08:53-04:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>CNTX: WALKER LUKE NATHANIEL (DIR) Filed a Form 3, Becoming a Registered Insider at CONTEXT THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-6053450" ></link>
<id>urn:uuid:5cfe9c35-eb09-be85-0ff4-092b53d119ec</id>
<updated>2024-09-05T08:01:50-04:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>CNTX: DANSKY ULLMANN CLAUDIO (O) Filed a Form 3, Becoming a Registered Insider at CONTEXT THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-6037426" ></link>
<id>urn:uuid:edabfdc0-fcc8-8189-2bd2-716a757e08ed</id>
<updated>2024-08-01T17:15:17-04:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>CNTX: LEHR MARTIN A (CEO,DIR) Bought (AB) 5,823 Shares of CONTEXT THERAPEUTICS INC for $0.84 on 2/21</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-5710182" ></link>
<id>urn:uuid:0009ec43-6593-8a3b-22df-96bf2648b694</id>
<updated>2023-02-21T20:05:37-05:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>CNTX: LEHR MARTIN A (CEO,DIR) Bought (AB) 5,606 Shares of CONTEXT THERAPEUTICS INC for $0.87 on 2/13</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-5700508" ></link>
<id>urn:uuid:fccf3b1c-b467-86b8-fdfc-f5ac643a8f95</id>
<updated>2023-02-13T16:03:23-05:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>CNTX: LEHR MARTIN A (CEO,DIR) Bought (AB) 5,040 Shares of CONTEXT THERAPEUTICS INC for $0.97 on 2/6</title>
<link href="http://www.insiderinsights.com/company/cntx/context-therapeutics-inc/id-5694509" ></link>
<id>urn:uuid:84a4d357-9e8e-95bc-de25-9dd28d037f77</id>
<updated>2023-02-06T16:03:09-05:00</updated>
<summary type="html" ><![CDATA[CONTEXT THERAPEUTICS INC (CNTX). Recent Price: $2.34. Mkt Cap:215.0mm. 10D Vol: 1.2mm]]></summary>
</entry>
</feed>